<http://webisa.webdatacommons.org/prov/3515439>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/448176956> .
<http://webisa.webdatacommons.org/448176956>	<http://www.w3.org/ns/prov#value>	"Enthusiasm is reflected in Bristol's valuation: The drugmaker's price-to-earnings ratio of roughly 28 times is a premium to its industry average of less than 25." .
<http://webisa.webdatacommons.org/448176956>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<fool.com> .
<http://webisa.webdatacommons.org/448176956>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .